Woman Receives Leukemia Diagnosis Despite Doctor Initially Deeming Bloodwork as ‘Normal’
:max_bytes(150000):strip_icc():format(jpeg)/Anabel-Brenner-101625-9-aa60be6083b04add91d413771db31a77.jpg)

Anabel Brenner Schleicher’s life took an unexpected turn when a routine check-up for a swollen lymph node led to a devastating diagnosis of leukemia. Schleicher, a medical student with dreams of becoming a nurse practitioner in Georgia, had her world flipped upside down after noticing the enlarged lymph node in March 2025. Initially, the 26-year-old and her fiancé were busy planning their wedding and focusing on their studies, but the discovery of the lymph node marked the beginning of a life-altering journey.

Despite not experiencing any other symptoms at the time, Schleicher noticed a concerning trend of more enlarged lymph nodes appearing on her neck. After two weeks without improvement, she sought medical attention and underwent routine blood work, which surprisingly showed normal results. However, as more lymph nodes continued to swell, she was referred to an ENT specialist who recommended a follow-up in six weeks if the swelling persisted.
Anabel Brenner Schleicher persistently pursued answers as she noticed more enlarged lymph nodes, leading to a biopsy in late May. Unfortunately, due to mishandling of her biopsy sample at the lab, she had to undergo a second biopsy on July 1. This delay in obtaining a definitive diagnosis was harrowing for Schleicher as her condition continued to worsen with the appearance of more lymph nodes in her body.
After the second biopsy revealed alarming results, Schleicher received the devastating news of being diagnosed with T-cell acute lymphoblastic leukemia on July 28, 2025. The delay in diagnosis meant that her treatment also had to be expedited, with aggressive therapy scheduled to begin on July 31. With her impending hospital admission, Schleicher and her fiancé decided to accelerate their wedding plans, exchanging vows in a heartfelt ceremony organized within just 12 hours by friends and family.
As of October 2025, Schleicher is undergoing chemotherapy in the consolidation phase, a follow-up treatment stage aimed at eradicating any residual cancer cells post-induction therapy. The road ahead involves several phases of treatment, including maintenance therapy over the next two years. Schleicher’s resilience and positive outlook shine through as she faces the challenges posed by her diagnosis.
Navigating leukemia treatment has required Schleicher to make significant lifestyle adjustments, with social activities on hold due to her weakened immune system. Despite the hurdles, she remains optimistic, urging others facing similar battles to embrace both the good and bad days while leaning on their support systems for strength. Through her journey, Schleicher embodies courage and determination in her fight against cancer, leaving a poignant message for others grappling with similar adversities.
The ordeal faced by Anabel Brenner Schleicher shines a light on the importance of timely and accurate medical diagnoses in managing serious health conditions. Her story serves as a reminder of the resilience and fortitude exhibited by individuals confronting life-altering challenges, resonating with readers worldwide.
Stay tuned for further updates on Schleicher’s journey as she strives towards remission and a future free from the constraints of leukemia.
